Clinical Trial Update: Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating early antiplatelet therapy after intravenous thrombolysis for acute ischemic stroke; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Capital Medical University | Conditions: Acute Ischemic Stroke, Cerebral Infarction | Phase 3 | Status: RECRUITING